Pioneering the Development of Automated Technologies for Cell-Based Therapeutics and Bioprocessing

For more than two decades ThermoGenesis Holdings, Inc. has developed and commercialized novel cell processing systems and devices providing global researchers, biomanufacturing organizations and clinicians with highly efficient cell processing devices which helped them to deliver better outcomes in various applications in the cell and gene therapy field.

Clinical BioBanking
With over 20 years of providing cord blood to banks hospitals, researchers and stem clinicians with systems designed to handle stem cells with the highest level of precision, safety, and confidence.
Point-of-Care Solutions
We develop products to obtain bone marrow concentrates easily, consistently, and reliably from bone marrow aspirates at the point-of-care with minimal red blood cell contamination.
Cellular Processing
The first step in the process is often the most important. That's why we have created closed-system novel and innovative technologies aimed at advancing cell therapies to the clinic.

Recent News

Four Tips to Consider for Cryopreservation of Cell Therapies

Cryopreservation is the process of using ultra-low temperatures to preserve living cells for long periods of time. It is an essential aspect of the cell manufacturing process of many cell therapies. While there are multiple factors to consider for developing a cryopreservation process that will ensure safe and effective manufacturing of cell therapies, below are … Continued

The Importance of Automated Cell Washing for Cell Manufacturing

As more and more cell and gene therapies are being developed, there is an emerging need for the industrialization of cell manufacturing. With greater production also comes more regulation, and the industry is in need of processes that are scalable and still meet the requirements of Good Manufacturing Practices (GMP) for cell manufacturing.   Cell … Continued

Getting to Know Our Vice President of Operations – Mindy Wilke-Douglas 

Mindy Wilke-Douglas, currently the Vice President of Operations, has been with ThermoGenesis since 2008. During a company-wide restructuring, she went back to the academic field, but eagerly accepted the opportunity to return when it became available. That’s how much she believes in the mission of the company and in the passion and work ethic that … Continued

ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2021 and Provide a Corporate Strategic Update

Conference Call to be Held on May 13, 2021 RANCHO CORDOVA, Calif., May 6, 2021 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the first quarter ended March 31, 2021 … Continued

Click below and be the first to hear about the latest news, breakthroughs, and products with the ThermoGenesis newsletter delivered directly to your inbox.
How may we help?